Literature DB >> 35836903

Clinical efficacy and safety of comprehensive nursing intervention in acute leukemia patients with myelosuppression after chemotherapy.

Xiaoqian Han1, Lihua Tian1.   

Abstract

OBJECTIVE: To investigate the clinical efficacy and safety of comprehensive nursing intervention in acute leukemia patients with myelosuppression after chemotherapy.
METHODS: Eighty acute leukemia patients with myelosuppression after chemotherapy admitted to our hospital from April 2018 to December 2021 were selected and divided, according to the nursing mode, as the conventional group (n=40) with routine nursing mode and the comprehensive group (n=40) with the comprehensive nursing mode. Patients' anxiety (Self-Rating Anxiety Scale, SAS) scores, depression (Self-Rating Depression Scale, SDS) scores, occurrence of complications, nursing satisfaction, nursing experience, complaint rate, and Visual Analogue Scale (VAS) score were compared between the two groups so as to analyze the efficacy and safety of comprehensive nursing intervention. The improvement of quality of life in the two groups was observed and analyzed using the short form of quality of life measurement (WHOQOL-BREF). Logistic regression analysis was performed to analyze the risk factors for nosocomial infection in patients with comprehensive nursing intervention.
RESULTS: No statistically significant differences in SAS and SDS scores between the two groups were found prior nursing (P>0.05), while after nursing, scores in the two groups both decreased, with those in the comprehensive group significantly lower than in the conventional group (P<0.05). The incidence of complications after nursing in the comprehensive group was significantly lower than that in the conventional group, and the difference was statistically significant (P<0.05). Nursing satisfaction of patients in the comprehensive group were significantly higher than that in the conventional group (P<0.05). After nursing, the nursing experience of the comprehensive group was significantly better than that of the conventional group (P<0.05); the complaint rate of the comprehensive group was significantly lower than that of the conventional group (P<0.05); before nursing, there was no significant difference in the VAS scores between the two groups of patients (P>0.05); after nursing, the VAS score of the comprehensive group was significantly lower than that of the conventional group (P<0.05). Before nursing, there was no significant difference in WHOQOL-BREF scores between the two groups (P>0.05); after nursing, the comprehensive group was higher than the conventional group. Among the 40 patients in the comprehensive nursing group, 15 patients developed infection. The number of neutrophils, age above 40, white blood cell count, hemoglobin content, high-intensity chemotherapy and glucocorticoid therapy were independent risk factors for nosocomial infection in patients with comprehensive nursing intervention (P<0.05).
CONCLUSION: Comprehensive nursing intervention for patients with myelosuppression after chemotherapy for acute leukemia can effectively improve the patient's nursing experience, reduce the patient's complaint rate, alleviate the patient's physical pain, relieve the patient's anxiety, depression and other negative emotions, and reduce the patient's complications, suggesting that comprehensive nursing intervention exerts better clinical efficacy and has high safety, which merits promotion clinically. AJTR
Copyright © 2022.

Entities:  

Keywords:  Comprehensive nursing intervention; acute leukemia; chemotherapy; myelosuppression phase

Year:  2022        PMID: 35836903      PMCID: PMC9274587     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   3.940


  20 in total

1.  The application effect analysis of personalized health education in acute leukemia nursing.

Authors:  Cuiping Zhang; Yanqin Mao; Fang Tang; Xiang Xu
Journal:  Am J Transl Res       Date:  2021-03-15       Impact factor: 4.060

2.  Linezolid is safe on platelet count for AML patients during myelosuppression after consolidation chemotherapy.

Authors:  Ting Shi; Shuqi Zhao; Jingjing Zhu; Lixia Zhu; Xiudi Yang; Wanzhuo Xie; Xiujin Ye
Journal:  J Clin Pharm Ther       Date:  2020-05-13       Impact factor: 2.512

3.  Antineoplastic chemotherapy in Jehovah's Witness patients with acute myelogenous leukemia refusing blood products - a matched pair analysis.

Authors:  Stefan Wilop; Rainhardt Osieka
Journal:  Hematology       Date:  2017-12-07       Impact factor: 2.269

4.  The effect of an oral care protocol and honey mouthwash on mucositis in acute myeloid leukemia patients undergoing chemotherapy: a single-blind clinical trial.

Authors:  Arezoo Khanjani Pour-Fard-Pachekenari; Azad Rahmani; Akram Ghahramanian; Mohammad Asghari Jafarabadi; Tonia C Onyeka; Arefeh Davoodi
Journal:  Clin Oral Investig       Date:  2018-09-11       Impact factor: 3.573

5.  Cluster nursing strategy for preventing perianal infection in leukemia patients after chemotherapy.

Authors:  Xuxia Luo; Lixia Zhu; Caihan Yin; Yanfeng Wu; Danyang Li; Xiujin Ye
Journal:  Panminerva Med       Date:  2020-06-04       Impact factor: 5.197

6.  [A single-center, randomized controlled trial of PEG-rhG-CSF and common rhG-CSF to promote neutrophil recovery after induction chemotherapy in newly diagnosed acute myeloid leukemia].

Authors:  K Q Liu; Y Wang; Z Zhao; D Lin; C L Zhou; B C Liu; X Y Gong; X L Zhao; S N Wei; G J Zhang; B F Gong; Y Li; Y T Liu; Y C Mi; J X Wang; H Wei
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2019-06-14

7.  [Reduction of FXIII during myelosuppression in acute leukemia after chemotherapy and adverse relation with bleeding events].

Authors:  Y Z Wang; B Y Tan; L Li; Z J Li
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2020-01-14

Review 8.  Venetoclax for the treatment of newly diagnosed acute myeloid leukemia in patients who are ineligible for intensive chemotherapy.

Authors:  Guillaume Richard-Carpentier; Courtney D DiNardo
Journal:  Ther Adv Hematol       Date:  2019-10-23

9.  Development and Effects of Leukemia Nursing Simulation Based on Clinical Reasoning.

Authors:  Aeri Jang; Miok Song; Suhyun Kim
Journal:  Int J Environ Res Public Health       Date:  2021-04-15       Impact factor: 3.390

10.  Allopurinol use during pediatric acute lymphoblastic leukemia maintenance therapy safely corrects skewed 6-mercaptopurine metabolism, improving inadequate myelosuppression and reducing gastrointestinal toxicity.

Authors:  Gordon Cohen; Stacy Cooper; Edward Allan Sison; Colleen Annesley; Mariam Bhuiyan; Patrick Brown
Journal:  Pediatr Blood Cancer       Date:  2020-09-10       Impact factor: 3.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.